Scholar IQ
Try ScholarIQ free
Upload Records Snowball Search Search OpenAlex
About the database
ScholarIQanswers from OpenAlex

Venetoclax in Combination with Obinutuzumab in Previously Untreated Fit Patients with Chronic Lymphocytic Leukemia: A Canadian Cost-Utility Analysis

PaperCitations, authors & open-access status

Venetoclax in Combination with Obinutuzumab in Previously Untreated Fit Patients with Chronic Lymphocytic Leukemia: A Canadian Cost-Utility Analysis is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 0 citations, 2025 year and gold oa status.

0
Citations
2025
Year
gold
OA Status

Related on ScholarIQ

Nancy Paul Roc
Author
PharmacoEconomics - Open
Journal
Chronic Lymphocytic Leukemia Research
Topic
Chronic Lymphocytic Leukemia Research
Topic
Acute Lymphoblastic Leukemia research
Topic
470M+ articles · free account